Search For "kirill dmitriev"

India key production partner for Russia's Sputnik V vaccine, says
Updated : 3 weeks, 5 days ago IST
Moscow [Russia], February 2 (ANI): India is the key production partner for Russia's Sputnik V vaccine against the coronavirus, Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund (RDIF) said on Tuesday.
Read More
Russian COVID-19 vaccine in phase 3 trial, to cost below USD 10 pe
Updated : 1 month, 1 week ago IST
New Delhi [India], January 21 (ANI): The Russian COVID-19 vaccine 'Sputnik V' will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
Read More
RDIF to deliver 150 million doses of Sputnik V to Brazil in 2021,
Updated : 1 month, 2 weeks ago IST
Moscow [Russia], January 13 (ANI/Sputnik): The Russian Direct Investment Fund (RDIF) will deliver 10 million doses of Sputnik V coronavirus vaccine to Brazil in the first quarter of 2021, with a total of 150 million doses to be delivered this year, according to the vaccine's official Twitter
Read More
Sputnik V can be highly effective against new COVID-19 strain: Vac
Updated : 2 months, 1 week ago IST
Moscow [Russia], December 21 (ANI): Sputnik V, the world's first COVID-19 vaccine, will be "highly effective" against the new strain of coronavirus found in Europe, said Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund, the company which codeveloped the vaccin
Read More
India to produce 300 million doses of Sputnik V vaccine
Updated : 2 months, 1 week ago IST
Moscow [Russia], December 18 (ANI): India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said.
Read More
Covid-19: Russia's Sputnik V vaccine is 95 per cent effective, che
Updated : 3 months, 1 week ago IST
Moscow [Russia], November 24 (ANI): The developers of Sputnik V coronavirus vaccine announced on Tuesday that it had an efficacy rate or 95 per cent based on the second interim analysis of clinical data.
Read More
Suspension of AstraZeneca COVID-19 vaccine trials showed fallacy o
Updated : 5 months, 2 weeks ago IST
Moscow [Russia], September 13 (ANI): Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev on Saturday said that temporary suspension of AstraZeneca COVID-19 vaccine candidate trials clearly showed the "fallacy of the approach" when countries "exclusively rely on novel and untested platf
Read More
Clinical trial of Sputnik V Coronavirus vaccine to begin this mont
Updated : 5 months, 3 weeks ago IST
Moscow [Russia], September 7 (ANI): The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Monday.
Read More
Russia in talks with India, drug manufactures for production of Sp
Updated : 5 months, 3 weeks ago IST
New Delhi [India], September 4 (ANI): Russia is in close dialogue with the Indian government and the leading drug manufactures of India regarding the localization of production of Sputnik V vaccine in India, said Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Friday.
Read More
'Secret behind high speed of Russia's COVID-19 vaccine creation wa
Updated : 6 months, 3 weeks ago IST
Moscow [Russia], August 11 (ANI): After the first coronavirus vaccine in the world was registered in Russia, Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev said, in his opinion piece for Sputnik, that the secret behind the high speed of Russia's COVID-19 vaccine creation was the c
Read More
Moscow, Riyadh to sign agreement on launching satellite from Saudi
Updated : 1 year, 4 months ago IST
Riyadh [Saudi Arabia], Oct 14 (Sputnik/ANI): Russia and Saudi Arabia will sign an agreement on launching a satellite from the kingdom's territory with the use of Russian technologies, as per Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev.
Read More